Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-12-21

Clinical Trial Update: Safety & Efficacy of AlloRx SC® in PTHS Patients [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on safety and efficacy of AlloRx SC® in Pitt Hopkins Syndrome across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AlloRx SC®

Snippet

Sponsor: Vitro Biopharma Inc. | Conditions: Pitt Hopkins Syndrome | Phase 1, Phase 2 | Status: UNKNOWN